Optimizing treatment for metastatic renal cell carcinoma

Article Properties
Cite
Patard, Jean-Jacques, et al. “Optimizing Treatment for Metastatic Renal Cell Carcinoma”. Expert Review of Anticancer Therapy, vol. 11, no. 12, 2011, pp. 1901-1, https://doi.org/10.1586/era.11.177.
Patard, J.-J., Porta, C., Wagstaff, J., & Gschwend, J. E. (2011). Optimizing treatment for metastatic renal cell carcinoma. Expert Review of Anticancer Therapy, 11(12), 1901-1911. https://doi.org/10.1586/era.11.177
Patard, Jean-Jacques, Camillo Porta, John Wagstaff, and Juergen E Gschwend. “Optimizing Treatment for Metastatic Renal Cell Carcinoma”. Expert Review of Anticancer Therapy 11, no. 12 (2011): 1901-11. https://doi.org/10.1586/era.11.177.
Patard JJ, Porta C, Wagstaff J, Gschwend JE. Optimizing treatment for metastatic renal cell carcinoma. Expert Review of Anticancer Therapy. 2011;11(12):1901-1.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
The Epidemiology of Renal Cell Carcinoma European Urology
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Medicine (General)
 625 2011
Stage migration and increasing proportion of favorable‐prognosis metastatic renal cell carcinoma patients

 Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 36 2010
Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma Cancer Treatment Reviews
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 75 2010
10.1200/JCO.2009.24.7759 2010
10.1200/JCO.2009.26.5561 2010
Refrences Analysis
Category Category Repetition
Medicine: Medicine (General)27
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens15
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology4
Medicine: Internal medicine4
Medicine: Surgery1
Technology: Chemical technology: Biotechnology1
Science: Microbiology1
Science: Biology (General)1
Science: Chemistry: Organic chemistry: Biochemistry1
The category Medicine: Medicine (General) 27 is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine and European Urology. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis Clinical Genitourinary Cancer
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology
  • Medicine: Medicine (General)
 17 2015
Proteinuria with first-line therapy of metastatic renal cell cancer

 Journal of Oncology Pharmacy Practice
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 8 2014
Sequential therapy in metastatic clear cell renal carcinoma: TKI–TKI vs TKI–mTOR Expert Review of Anticancer Therapy
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
 14 2012
Citations Analysis
Category Category Repetition
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens3
Medicine: Medicine (General)2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the genitourinary system. Urology1
Medicine: Therapeutics. Pharmacology1
Medicine: Public aspects of medicine: Toxicology. Poisons1
The category Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 3 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Sequential therapy in metastatic clear cell renal carcinoma: TKI–TKI vs TKI–mTOR and was published in 2012. The most recent citation comes from a 2015 study titled Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis. This article reached its peak citation in 2015, with 1 citations. It has been cited in 3 different journals. Among related journals, the Journal of Oncology Pharmacy Practice cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year